Back to Journals » OncoTargets and Therapy » Volume 12

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy

Total article views   HTML views PDF downloads Totals
6,278 Dovepress* 5,006+ 1,059 6,065
PubMed Central* 1,272 525 1,797
Totals 6,278 1,584 7,862
*Since 27 November 2019
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 6 6

View citations on PubMed Central and Google Scholar